BackOrphazyme A/S Overview

Orphazyme A/S Long Term Debt

Track Orphazyme A/S's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Orphazyme A/S Long Term Debt History

Loading

Orphazyme A/S vs. peers: Long Term Debt Comparison

Loading

Orphazyme A/S Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPHY) FAQ

As of the most recent data (June 2024), ORPHY shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPHY's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPHY's long-term debt over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Orphazyme A/S's long-term debt is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.